Doxorubicin—an agent with multiple mechanisms of anticancer activity

M Kciuk, A Gielecińska, S Mujwar, D Kołat… - Cells, 2023 - mdpi.com
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens
currently in clinical use. However, the precise mechanisms of DOX's action are not fully …

ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response

AN Blackford, SP Jackson - Molecular cell, 2017 - cell.com
In vertebrate cells, the DNA damage response is controlled by three related kinases: ATM,
ATR, and DNA-PK. It has been 20 years since the cloning of ATR, the last of the three to be …

Targeting DNA repair in cancer: beyond PARP inhibitors

JS Brown, B O'Carrigan, SP Jackson, TA Yap - Cancer discovery, 2017 - AACR
Germline aberrations in critical DNA-repair and DNA damage–response (DDR) genes
cause cancer predisposition, whereas various tumors harbor somatic mutations causing …

Causes and consequences of replication stress

MK Zeman, KA Cimprich - Nature cell biology, 2014 - nature.com
Replication stress is a complex phenomenon that has serious implications for genome
stability, cell survival and human disease. Generation of aberrant replication fork structures …

ATR/CHK1 inhibitors and cancer therapy

Z Qiu, NL Oleinick, J Zhang - Radiotherapy and Oncology, 2018 - Elsevier
The cell cycle checkpoint proteins ataxia-telangiectasia-mutated-and-Rad3-related kinase
(ATR) and its major downstream effector checkpoint kinase 1 (CHK1) prevent the entry of …

[HTML][HTML] DNA repair targeted therapy: The past or future of cancer treatment?

NS Gavande, PS VanderVere-Carozza… - Pharmacology & …, 2016 - Elsevier
The repair of DNA damage is a complex process that relies on particular pathways to
remedy specific types of damage to DNA. The range of insults to DNA includes small …

Activation of the ATR kinase by the RPA-binding protein ETAA1

P Haahr, S Hoffmann, MAX Tollenaere, T Ho… - Nature cell …, 2016 - nature.com
Activation of the ATR kinase following perturbations to DNA replication relies on a complex
mechanism involving ATR recruitment to RPA-coated single-stranded DNA via its binding …

ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells

M Kwok, N Davies, A Agathanggelou… - Blood, The Journal …, 2016 - ashpublications.org
TP53 and ataxia telangiectasia mutated (ATM) defects are associated with genomic
instability, clonal evolution, and chemoresistance in chronic lymphocytic leukemia (CLL) …

ALTernative telomere maintenance and cancer

RL Dilley, RA Greenberg - Trends in cancer, 2015 - cell.com
Activation of a telomere maintenance mechanism (TMM) is permissive for replicative
immortality and a hallmark of human cancer. While most cancers rely on reactivation of …

Molecular pathways: targeting ATR in cancer therapy

LM Karnitz, L Zou - Clinical cancer research, 2015 - AACR
The human ATR gene encodes a kinase that is activated by DNA damage and replication
stress as a central transducer of a checkpoint signaling pathway. Once activated, ATR …